Can yoga and relaxation help young cancer survivors? new study tests a Stress-Busting program
NCT ID NCT03768336
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a group program called the Relaxation Response Resiliency Program (3RP-AYA) for adolescents and young adults who finished cancer treatment in the last 5 years. The program uses mind-body techniques like imagery, relaxation, and yoga to reduce stress and build resilience. Researchers want to see if the program is feasible and acceptable to participants. The study involves 72 people and compares those who get the program right away to those who wait about 2 months.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Relaxation Response Resiliency Program (3RP-AYA) – a group program using mind-body techniques like imagery, relaxation, and yoga
What this could lead to
If it works, this could provide a practical way to help young cancer survivors manage stress and improve their well-being.
What could go wrong
This is a small, early feasibility study with only 72 participants. It is not designed to prove the program works, only that it is acceptable and doable.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Massachusetts General Hospital Cancer Center
Boston, Massachusetts, 02214, United States